Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells. - Wikidata - awgldk - TriplyDB

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

http://www.wikidata.org/entity/Q34440418

about

Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.The mitochondrial genome is a "genetic sanctuary" during the oncogenic process.Cellular and physiological roles for phospholipase D1 in cancer.Activators of PKM2 in cancer metabolism.Synthesis and photophysics of an octathioglycosylated zinc(II) phthalocyanine.Human phospholipase D activity transiently regulates pyrimidine biosynthesis in malignant gliomas Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.The mTOR inhibitor AZD8055 inhibits proliferation and glycolysis in cervical cancer cells Phosphatidic acid and lipid-sensing by mTOR mTOR inhibitor AZD8055 inhibits proliferation and induces apoptosis in laryngeal carcinoma.New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy.Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics.N-Methyl-N-nitrosourea as a mammary carcinogenic agent.Death-associated proliferation kinetic in normal and transformed cells.Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LH(BETA)T(AG) retinal tumors.Iodine-125 interstitial brachytherapy reduces tumor growth via Warburg effect inhibition in non-small cell lung cancer A549 ×enografts

P2860

Q24603549-EEE9D3DB-E17D-4FA0-9E63-C7929D2ACDFF Q33790538-7402CDAB-B6AD-45ED-B780-3BD2EDC10AC2 Q33999445-D985A82E-FB29-4EB0-9BFB-E78C59E908DD Q34044529-59B8AD21-D7E3-4FD5-9320-BF0A96CE086F Q35215989-C8220C8A-BEE5-458C-839A-A61E31894EC8 Q35237683-8D736643-D1FB-43C8-8901-5583FDFF2B41 Q35612199-29DB646A-F271-4EAA-AA04-935731CB3920 Q35691988-8C3B7DAA-9625-4297-9762-09D3AFF0F74D Q36611732-B8EE8731-5912-4301-A85C-2309700C4E15 Q36893382-BD009DB7-B3CA-4C60-8125-CDBE0D4E0859 Q37597433-AE75DCF9-04AF-45BB-9AE4-22661A254719 Q38036571-3FA34D1C-B548-4AFB-ABBE-005F91904225 Q38575844-B0847A21-9CF1-4F40-B25F-6B6B9096780D Q38589651-4C66E5A1-55BB-438C-9C05-79E361096E55 Q39376291-779E33EB-EBA7-44A4-BCA2-B2C4954FE192 Q41824416-937FFFE3-C86C-4AB5-B962-B9EDAC8BCA63 Q57788714-18C2242F-8811-4CC8-9152-8A3111FF36B8

P2860

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

http://www.wikidata.org/entity/Q34440418

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

@ast

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

@en

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

@nl

type

label

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

@ast

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

@en

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

@nl

prefLabel

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

@ast

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

@en

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

@nl

P1433

Q34440418-08C869F4-6833-4C58-AC6C-CBA0057AC43D

P1476

Q34440418-8F1F0368-74BD-4094-B589-1665098BAAC2

P2093

Q34440418-0B41F977-385C-4C77-88FB-42233B5F261E

Q34440418-24315468-48DC-4398-B5D3-E7953BDA3209

Q34440418-34108FE1-7754-4590-86F5-EB10FB7A5AFF

Q34440418-50F6A11F-A1CC-4182-9C77-760C24A2947E

Q34440418-671B1395-C882-4E36-B599-DD0393B46986

Q34440418-B2C8604B-C444-4148-85AB-95707A6BBB83

Q34440418-E29E64F6-7017-4613-83FE-98766A9E8FE1

Q34440418-EB59BB34-0A5F-4330-A011-81D7CBD1C890

P2860

Q34440418-08A2DE31-1681-4527-A421-E75C12260E32

Q34440418-15296FCE-C8D8-4408-A90F-0800B32155CC

Q34440418-1E0EAE3A-CBB2-49F9-B8FC-6505A3043B97

Q34440418-2FD8B4B2-0734-42BB-98F7-512B943A707F

Q34440418-3000C9C9-2030-4DA6-92D6-CE5405E28724

Q34440418-3D68146A-1E4C-45C3-9455-01610607A449

Q34440418-41E0286B-F16F-4BDC-BC39-48C135DC95DD

Q34440418-42A55F03-12F7-4409-801E-E5AB70E6076B

Q34440418-484870FE-1560-4ADA-901D-7C4AAEB1095D

Q34440418-4A5B3D37-2F3F-43B5-8645-FDE02183E6F6

P304

Q34440418-068954A6-B03F-4235-9B89-67B948F196D0

P31

Q34440418-9546E326-2243-4B3A-BBEA-4E4A6C5EFBBA

P356

Q34440418-A71FFA35-57EA-4D64-A9A8-538AB381799A

P407

Q34440418-D353B2DF-6854-4A1B-811D-2E3CBBC8BAFB

P433

Q34440418-94E1F779-0907-4BB8-9A38-39CA8363E43F

P478

Q34440418-BDDC1237-6F54-419C-80F4-38170BE4F77B

P577

Q34440418-BB24526E-5543-46BC-89F2-2E466D79AD12

P5875

Q34440418-25F2B329-60FB-4902-9148-D3FA92113543

P698

Q34440418-6D721C3F-76B7-4648-ACF0-36B739CBA332

P932

Q34440418-7EF73F5B-8B36-4906-913F-4A0FCC81F284

P356

J.CANLET.2010.08.006

P1433

P1476

Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.

@en

P2093

Alfredo Toschi

http://www.w3.org/2001/XMLSchema#string

C Michael Drain

http://www.w3.org/2001/XMLSchema#string

David A Foster

http://www.w3.org/2001/XMLSchema#string

Evan Lee

http://www.w3.org/2001/XMLSchema#string

Michael Ohh

http://www.w3.org/2001/XMLSchema#string

Noga Gadir

http://www.w3.org/2001/XMLSchema#string

Paige Yellen

http://www.w3.org/2001/XMLSchema#string

Sebastian Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2

Understanding the Warburg effect: the metabolic requirements of cell proliferation

A new view of carcinogenesis and an alternative approach to cancer therapy

Brick by brick: metabolism and tumor cell growth

AKT/PKB signaling: navigating downstream

Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth

Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR

TOR signaling in growth and metabolism

P304

72-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CANLET.2010.08.006

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

299

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46094967

http://www.w3.org/2001/XMLSchema#string

P698

20805015

http://www.w3.org/2001/XMLSchema#string

P932

3010225

http://www.w3.org/2001/XMLSchema#string